Reduced expression of SM22 is correlated with low autophagy activity in human colorectal cancer

Pathology Research and Practice

Volumn 209, Issue 4, 2013, Pages 237-243

  Xie, Xiao Li ^a   Liu, Ya Bin ^a   Liu, Yue Ping ^a   Du, Bin Liang ^a   Li, Yang ^a   Han, Mei ^a   Li, Bing Hui ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Autophagy; Colorectal cancer; P62; SM22

Indexed keywords

PROTEIN P62; TRANSGELIN;

ADULT; AGED; ARTICLE; AUTOPHAGY; CANCER STAGING; CELL STRAIN HCT116; CELL STRAIN HT29; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; AUTOPHAGY; BLOTTING, WESTERN; COLORECTAL NEOPLASMS; DOWN-REGULATION; FEMALE; HCT116 CELLS; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; MUSCLE PROTEINS; RATS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84876304301     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2013.02.007     Document Type: Article

References (28)

1. Zhao L., Wang H., Deng Y.J., Wang S., Liu C., Jin H., Ding Y.Q. Transgelin as a suppressor is associated with poor prognosis in colorectal carcinoma patients. Mod. Pathol. 2009, 22:786-796.
2. Zhang J.C., Kim S., Helmke B.P., Yu W.W., Du K.L., Lu M.M., Strobeck M., Yu Q., Parmacek M.S. Analysis of sm22alpha-deficient mice reveals unanticipated insights into smooth muscle cell differentiation and function. Mol. Cell. Biol. 2001, 21:1336-1344.
3. Yu H., Konigshoff M., Jayachandran A., Handley D., Seeger W., Kaminski N., Eickelberg O. Transgelin is a direct target of tgf-beta/smad3-dependent epithelial cell migration in lung fibrosis. FASEB J. 2008, 22:1778-1789.
4. Gerolymos M., Karagianni F., Papasotiriou M., Kalliakmani P., Sotsiou F., Charonis A., Goumenos D.S. Expression of transgelin in human glomerulonephritis of various etiology. Nephron Clin. Pract. 2011, 119:c74-c82.
5. Yang Z., Chang Y.J., Miyamoto H., Ni J., Niu Y., Chen Z., Chen Y.L., Yao J.L., di Sant'Agnese P.A., Chang C. Transgelin functions as a suppressor via inhibition of ara54-enhanced androgen receptor transactivation and prostate cancer cell growth. Mol. Endocrinol. 2007, 21:343-358.
6. Yeo M., Park H.J., Kim D.K., Kim Y.B., Cheong J.Y., Lee K.J., Cho S.W. Loss of sm22 is a characteristic signature of colon carcinogenesis and its restoration suppresses colon tumorigenicity in vivo and in vitro. Cancer 2010, 116:2581-2589.
7. Shields J.M., Rogers-Graham K., Der C.J. Loss of transgelin in breast and colon tumors and in rie-1 cells by ras deregulation of gene expression through raf-independent pathways. J. Biol. Chem. 2002, 277:9790-9799.
8. Zhang Z.W., Yang Z.M., Zheng Y.C., Chen Z.D. Transgelin induces apoptosis of human prostate lncap cells through its interaction with p53. Asian J. Androl. 2010, 12:186-195.
9. Dong L.H., Wen J.K., Liu G., McNutt M.A., Miao S.B., Gao R., Zheng B., Zhang H., Han M. Blockade of the ras-extracellular signal-regulated kinase 1/2 pathway is involved in smooth muscle 22 alpha-mediated suppression of vascular smooth muscle cell proliferation and neointima hyperplasia. Arterioscler. Thromb. Vasc. Biol. 2010, 30:683-691.
10. Jaakkola P.M., Pursiheimo J.P. P62 degradation by autophagy: another way for cancer cells to survive under hypoxia. Autophagy 2009, 5:410-412.
11. Ichimura Y., Komatsu M. Selective degradation of p62 by autophagy. Semin. Immunopathol. 2010, 32:431-436.
12. Duran A., Linares J.F., Galvez A.S., Wikenheiser K., Flores J.M., Diaz-Meco M.T., Moscat J. The signaling adaptor p62 is an important nf-kappab mediator in tumorigenesis. Cancer Cell 2008, 13:343-354.
13. Su Y., Qian H., Zhang J., Wang S., Shi P., Peng X. The diversity expression of p62 in digestive system cancers. Clin. Immunol. 2005, 116:118-123.
14. Mathew R., Karp C.M., Beaudoin B., Vuong N., Chen G., Chen H.Y., Bray K., Reddy A., Bhanot G., Gelinas C., Dipaola R.S., Karantza-Wadsworth V., White E. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009, 137:1062-1075.
15. Mascaux C., Martin B., Verdebout J.M., Meert A.P., Ninane V., Sculier J.P. Fragile histidine triad protein expression in nonsmall cell lung cancer and correlation with ki-67 and with p53. Eur. Respir. J. 2003, 21:753-758.
16. Bozkurt K.K., Kapucuoglu N. Investigation of immunohistochemical eralpha erbeta and erbetacx expressions in normal and neoplastic breast tissues. Pathol. Res. Pract. 2012, 208:133-139.
17. Prasad P.D., Stanton J.A., Assinder S.J. Expression of the actin-associated protein transgelin (sm22) is decreased in prostate cancer. Cell Tissue Res. 2010, 339:337-347.
18. Mizushima N., Yoshimori T., Levine B. Methods in mammalian autophagy research. Cell 2010, 140:313-326.
19. Bjorkoy G., Lamark T., Brech A., Outzen H., Perander M., Overvatn A., Stenmark H., Johansen T. P62/sqstm1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 2005, 171:603-614.
20. Assinder S.J., Stanton J.A., Prasad P.D., Transgelin An actin-binding protein and tumour suppressor. Int. J. Biochem. Cell Biol. 2009, 41:482-486.
21. Thompson O., Moghraby J.S., Ayscough K.R., Winder S.J. Depletion of the actin bundling protein sm22/transgelin increases actin dynamics and enhances the tumourigenic phenotypes of cells. BMC Cell Biol. 2012, 13:1.
22. Wulfkuhle J.D., Sgroi D.C., Krutzsch H., McLean K., McGarvey K., Knowlton M., Chen S., Shu H., Sahin A., Kurek R., Wallwiener D., Merino M.J., Petricoin E.F., Zhao Y., Steeg P.S. Proteomics of human breast ductal carcinoma in situ. Cancer Res. 2002, 62:6740-6749.
23. Han M., Dong L.H., Zheng B., Shi J.H., Wen J.K., Cheng Y. Smooth muscle 22 alpha maintains the differentiated phenotype of vascular smooth muscle cells by inducing filamentous actin bundling. Life Sci. 2009, 84:394-401.
24. Gimona M., Kaverina I., Resch G.P., Vignal E., Burgstaller G. Calponin repeats regulate actin filament stability and formation of podosomes in smooth muscle cells. Mol. Biol. Cell 2003, 14:2482-2491.
25. Mizushima N., Yoshimori T. How to interpret lc3 immunoblotting. Autophagy 2007, 3:542-545.
26. Rosenfeldt M.T., Ryan K.M. The multiple roles of autophagy in cancer. Carcinogenesis 2011, 32:955-963.
27. Roy S., Debnath J. Autophagy and tumorigenesis. Semin. Immunopathol. 2010, 32:383-396.
28. Mathew R., White E. Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night. Curr. Opin. Genet. Dev. 2011, 21:113-119.